// App-Quantinova.ai

2331 : Role of Osteopontin, Cytokeratin K8 and Mircorrna‐122 As Biomarkers for Idiosyncratic Drug‐Induced Liver Injury and Acute Viral Hepatitis

Researchers

Presenter

  • A Cueto-Sanchez

Principal Investigators

  • E Martinez-Gomez

  • B Lpez-Longarela

  • Judith Sanabria Cabrera

  • R Sanjuan-Jimenez

  • A Ortega- Alonso

  • M Garcia-Cortes

  • R Rocio-Grande

  • Miguel Jimenez

  • Jj Daz-Mochn

  • Guruprasad P. Aithal

  • M I Lucena

  • M Robles-Diaz

  • Camilla Stephens

  • Raul J Andrade

Medical Centers

  • UGC Aparato Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain

  • Destina Genomics, Granada, Spain

  • Ciberehd, Madrid, Spain,

  • Servicio De Aparato Digestivo, Ibima, Hospital Universitario Regional De Málaga, Málaga, Spain,

  • Genyo - Pfizer-Universidad De Granada-Junta De Andalucia Centre for Genomics and Oncological Research, Granada, Spain

  • Granada, Spain,

  • Nottingham Digestive Diseases Centre and National Institute for Health Research

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Drug-induced liver injury

Biomarkers

  • Osteopontin

  • Cytokeratin 18

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved